The Veeva Field Trends 2022 report says 75% of healthcare providers want contact with drug field staff to be a mix of digital and in-person.
FDA clears a Neuronetics 510(k) for a new indication for its NeuroStar Advanced Therapy for Mental Health device, a transcranial magnetic stimulation ...
FDA warns Spains Bioiberica about CGMP deviations in its manufacturing of active pharmaceutical ingredients.
FDA warns Imprimis Rx that professional promotional materials for a compounded ophthalmic drug make false and misleading statements about the drug.
FDA lifts a clinical hold against Viking Therapeutics VK0214 in patients with X-linked adrenoleukodystrophy.
Merck halts a Phase 3 LYNK-003 trial investigating Lynparza (olaparib) with or without bevacizumab for treating patients with unresectable or metastat...
CDER director Patrizia Cavazzoni selects associate director for controlled substances Marta Sokolowska to serve as deputy Center director for substanc...
The Washington Legal Foundation says an OIG advisory opinion puts life sciences companies on notice to be cautious in the way they fund continuing edu...